ARTBIO, a Cambridge, MA-based biotech company advancing its pipeline and manufacturing capabilities, raised $132 million in a Series B fundraising round led by Sofinnova Investments with participation from B Capital, F-Prime Capital, and others.
More on VC News Daily →
